The results showed that ESRP2 transcripts were relatively low in fetal hepatocytes, activated in adult hepatocytes, and re‐silenced in HCC (Figure 1B), suggesting that ESRP2 is a novel oncofetal suppressor in HCC. This evidence concerns the gene ESRP2 and hepatocellular carcinoma.